It is often stated that imitation is the highest form of flattery. In the case of Chicago journalist, Malinda Skoda, expecting such sycophancy would be a proverbial waste of time. Simply put, she's the last of a dying breed. In a time where press and media are largely controlled by corporate interests, what the general public is offered to read and watch can no longer be considered objective and unbiased, but rehearsed and prejudiced, all in an effort to sway. This reality is not lost on Skoda, who continues to forge her own path, making powerful enemies at almost every turn.
Her goal being the same as it ever was: To get to the truth! No matter the cost! A chance encounter with the chairman and CEO of Mimema, brings her face to face with her toughest assignment yet-the newest player in the global race to eradicate neural abnormalities. On the surface, everything about the company sounds like a lark. Brain regeneration, memory restoration and enhancement. For the millions of families affected, however, it's like a dream come true. Unlike the rest of the hopefuls-hypnotized by the hype that Mimema is "changing lives, one patient at a time, " Skoda remains unconvinced; her instincts warning her that something more ominous is afoot. The burden of truth is often misery.
It is often stated that imitation is the highest form of flattery. In the case of Chicago journalist, Malinda Skoda, expecting such sycophancy would be a proverbial waste of time. Simply put, she's the last of a dying breed. In a time where press and media are largely controlled by corporate interests, what the general public is offered to read and watch can no longer be considered objective and unbiased, but rehearsed and prejudiced, all in an effort to sway. This reality is not lost on Skoda, who continues to forge her own path, making powerful enemies at almost every turn.
Her goal being the same as it ever was: To get to the truth! No matter the cost! A chance encounter with the chairman and CEO of Mimema, brings her face to face with her toughest assignment yet-the newest player in the global race to eradicate neural abnormalities. On the surface, everything about the company sounds like a lark. Brain regeneration, memory restoration and enhancement. For the millions of families affected, however, it's like a dream come true. Unlike the rest of the hopefuls-hypnotized by the hype that Mimema is "changing lives, one patient at a time, " Skoda remains unconvinced; her instincts warning her that something more ominous is afoot. The burden of truth is often misery.
